Insulin Resistance and Its Association With no Reflow Phenomenon After Primary PCI in Type II Diabetic STEMI Patients.
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorAssiut University
About this trial
To investigate the relationship between the TyG index, coronary lesion complexity assessed by the SYNTAX score, and the development of the no-reflow phenomenon in STEMI patients with T2DM.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Type 2 Diabetes Mellitus patients .
Undergoing PCI for STEMI.
Written informed consent obtained.
Disqualifiers
1. Individuals with a previous history of myocardial infarction (MI) or decompensated heart failure.
Trial design
Treatments tested in this trial
- PCI
Treatment groups
100 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov